Tumor cell-derived ISG15 promotes fibroblast recruitment in oral squamous cell carcinoma via CD11a-dependent glycolytic reprogramming
Cancer-associated fibroblast (CAF) recruitment and activation within the tumor microenvironment (TME) are increasingly acknowledged as drivers of oral squamous cell carcinoma (OSCC) tumor growth and metastasis. Therefore, the mechanisms underlying tumor cell and fibroblast crosstalk warrant further...
Saved in:
Published in | Oncogenesis (New York, NY) Vol. 14; no. 1; pp. 6 - 13 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
11.03.2025
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Cancer-associated fibroblast (CAF) recruitment and activation within the tumor microenvironment (TME) are increasingly acknowledged as drivers of oral squamous cell carcinoma (OSCC) tumor growth and metastasis. Therefore, the mechanisms underlying tumor cell and fibroblast crosstalk warrant further investigation. We discovered that ectopic interferon-stimulated gene 15 (ISG15) expression, which is a promising and novel oncoprotein biomarker elevated in a variety of cancers, enhanced OSCC growth and elevated collagen and α-smooth muscle actin (α-SMA) expression in ISG15-expressing tumors. Analysis of immunohistochemistry revealed high ISG15 expression in human oral tissues correlated with high expression of α-SMA and fibroblast activation protein (FAP). Fibroblast migration and recruitment by ISG15-expressing OSCC cells were confirmed by in vitro and in vivo experiments. Exogenous ISG15 induced fibroblast migration, morphological changes, and vimentin expression. Enrichment of glycolysis pathway genes, as well as increased glycolysis-related gene expression, glucose uptake, and lactate production were observed in ISG15-treated fibroblasts. Lactate release and fibroblast migration were blocked by a competitive inhibitor of glucose metabolism. Furthermore, the knockdown of integrin αL (ITGAL)/CD11a, a subunit of ISG15 receptor lymphocyte functional-associated antigen-1 (LFA-1), in immortalized fibroblasts diminished extracellular ISG15-mediated glycolysis and migration. Our findings suggest that ISG15 derived from OSCC cells interacts with fibroblasts through the LFA-1 receptor, leading to glycolytic reprogramming and promotion of fibroblast migration into the TME. |
---|---|
AbstractList | Cancer-associated fibroblast (CAF) recruitment and activation within the tumor microenvironment (TME) are increasingly acknowledged as drivers of oral squamous cell carcinoma (OSCC) tumor growth and metastasis. Therefore, the mechanisms underlying tumor cell and fibroblast crosstalk warrant further investigation. We discovered that ectopic interferon-stimulated gene 15 (ISG15) expression, which is a promising and novel oncoprotein biomarker elevated in a variety of cancers, enhanced OSCC growth and elevated collagen and α-smooth muscle actin (α-SMA) expression in ISG15-expressing tumors. Analysis of immunohistochemistry revealed high ISG15 expression in human oral tissues correlated with high expression of α-SMA and fibroblast activation protein (FAP). Fibroblast migration and recruitment by ISG15-expressing OSCC cells were confirmed by in vitro and in vivo experiments. Exogenous ISG15 induced fibroblast migration, morphological changes, and vimentin expression. Enrichment of glycolysis pathway genes, as well as increased glycolysis-related gene expression, glucose uptake, and lactate production were observed in ISG15-treated fibroblasts. Lactate release and fibroblast migration were blocked by a competitive inhibitor of glucose metabolism. Furthermore, the knockdown of integrin αL (ITGAL)/CD11a, a subunit of ISG15 receptor lymphocyte functional-associated antigen-1 (LFA-1), in immortalized fibroblasts diminished extracellular ISG15-mediated glycolysis and migration. Our findings suggest that ISG15 derived from OSCC cells interacts with fibroblasts through the LFA-1 receptor, leading to glycolytic reprogramming and promotion of fibroblast migration into the TME. Abstract Cancer-associated fibroblast (CAF) recruitment and activation within the tumor microenvironment (TME) are increasingly acknowledged as drivers of oral squamous cell carcinoma (OSCC) tumor growth and metastasis. Therefore, the mechanisms underlying tumor cell and fibroblast crosstalk warrant further investigation. We discovered that ectopic interferon-stimulated gene 15 (ISG15) expression, which is a promising and novel oncoprotein biomarker elevated in a variety of cancers, enhanced OSCC growth and elevated collagen and α-smooth muscle actin (α-SMA) expression in ISG15-expressing tumors. Analysis of immunohistochemistry revealed high ISG15 expression in human oral tissues correlated with high expression of α-SMA and fibroblast activation protein (FAP). Fibroblast migration and recruitment by ISG15-expressing OSCC cells were confirmed by in vitro and in vivo experiments. Exogenous ISG15 induced fibroblast migration, morphological changes, and vimentin expression. Enrichment of glycolysis pathway genes, as well as increased glycolysis-related gene expression, glucose uptake, and lactate production were observed in ISG15-treated fibroblasts. Lactate release and fibroblast migration were blocked by a competitive inhibitor of glucose metabolism. Furthermore, the knockdown of integrin αL (ITGAL)/CD11a, a subunit of ISG15 receptor lymphocyte functional-associated antigen-1 (LFA-1), in immortalized fibroblasts diminished extracellular ISG15-mediated glycolysis and migration. Our findings suggest that ISG15 derived from OSCC cells interacts with fibroblasts through the LFA-1 receptor, leading to glycolytic reprogramming and promotion of fibroblast migration into the TME. Cancer-associated fibroblast (CAF) recruitment and activation within the tumor microenvironment (TME) are increasingly acknowledged as drivers of oral squamous cell carcinoma (OSCC) tumor growth and metastasis. Therefore, the mechanisms underlying tumor cell and fibroblast crosstalk warrant further investigation. We discovered that ectopic interferon-stimulated gene 15 (ISG15) expression, which is a promising and novel oncoprotein biomarker elevated in a variety of cancers, enhanced OSCC growth and elevated collagen and α-smooth muscle actin (α-SMA) expression in ISG15-expressing tumors. Analysis of immunohistochemistry revealed high ISG15 expression in human oral tissues correlated with high expression of α-SMA and fibroblast activation protein (FAP). Fibroblast migration and recruitment by ISG15-expressing OSCC cells were confirmed by in vitro and in vivo experiments. Exogenous ISG15 induced fibroblast migration, morphological changes, and vimentin expression. Enrichment of glycolysis pathway genes, as well as increased glycolysis-related gene expression, glucose uptake, and lactate production were observed in ISG15-treated fibroblasts. Lactate release and fibroblast migration were blocked by a competitive inhibitor of glucose metabolism. Furthermore, the knockdown of integrin αL (ITGAL)/CD11a, a subunit of ISG15 receptor lymphocyte functional-associated antigen-1 (LFA-1), in immortalized fibroblasts diminished extracellular ISG15-mediated glycolysis and migration. Our findings suggest that ISG15 derived from OSCC cells interacts with fibroblasts through the LFA-1 receptor, leading to glycolytic reprogramming and promotion of fibroblast migration into the TME.Cancer-associated fibroblast (CAF) recruitment and activation within the tumor microenvironment (TME) are increasingly acknowledged as drivers of oral squamous cell carcinoma (OSCC) tumor growth and metastasis. Therefore, the mechanisms underlying tumor cell and fibroblast crosstalk warrant further investigation. We discovered that ectopic interferon-stimulated gene 15 (ISG15) expression, which is a promising and novel oncoprotein biomarker elevated in a variety of cancers, enhanced OSCC growth and elevated collagen and α-smooth muscle actin (α-SMA) expression in ISG15-expressing tumors. Analysis of immunohistochemistry revealed high ISG15 expression in human oral tissues correlated with high expression of α-SMA and fibroblast activation protein (FAP). Fibroblast migration and recruitment by ISG15-expressing OSCC cells were confirmed by in vitro and in vivo experiments. Exogenous ISG15 induced fibroblast migration, morphological changes, and vimentin expression. Enrichment of glycolysis pathway genes, as well as increased glycolysis-related gene expression, glucose uptake, and lactate production were observed in ISG15-treated fibroblasts. Lactate release and fibroblast migration were blocked by a competitive inhibitor of glucose metabolism. Furthermore, the knockdown of integrin αL (ITGAL)/CD11a, a subunit of ISG15 receptor lymphocyte functional-associated antigen-1 (LFA-1), in immortalized fibroblasts diminished extracellular ISG15-mediated glycolysis and migration. Our findings suggest that ISG15 derived from OSCC cells interacts with fibroblasts through the LFA-1 receptor, leading to glycolytic reprogramming and promotion of fibroblast migration into the TME. |
ArticleNumber | 6 |
Author | Fu, Yu-Ke Chen, Ya-Wen Lin, Su-Fang Liu, Shu-Chen Huang, Shih-Han Hsiao, Jenn-Ren Chen, Yu-Lin Jiang, Shih Sheng Chang, Jang-Yang Wang, Ssu-Han |
Author_xml | – sequence: 1 givenname: Ssu-Han surname: Wang fullname: Wang, Ssu-Han organization: National Institute of Cancer Research, National Health Research Institutes – sequence: 2 givenname: Yu-Lin surname: Chen fullname: Chen, Yu-Lin organization: National Institute of Cancer Research, National Health Research Institutes – sequence: 3 givenname: Shih-Han surname: Huang fullname: Huang, Shih-Han organization: National Institute of Cancer Research, National Health Research Institutes – sequence: 4 givenname: Yu-Ke surname: Fu fullname: Fu, Yu-Ke organization: National Institute of Cancer Research, National Health Research Institutes – sequence: 5 givenname: Su-Fang orcidid: 0000-0001-8706-2439 surname: Lin fullname: Lin, Su-Fang organization: National Institute of Cancer Research, National Health Research Institutes – sequence: 6 givenname: Shih Sheng surname: Jiang fullname: Jiang, Shih Sheng organization: National Institute of Cancer Research, National Health Research Institutes – sequence: 7 givenname: Shu-Chen surname: Liu fullname: Liu, Shu-Chen organization: Department of Biomedical Sciences and Engineering, National Central University – sequence: 8 givenname: Jenn-Ren surname: Hsiao fullname: Hsiao, Jenn-Ren organization: Department of Otolaryngology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University – sequence: 9 givenname: Jang-Yang surname: Chang fullname: Chang, Jang-Yang organization: Taipei Cancer Center, Taipei Medical University Hospital, TMU Research Center of Cancer Translational Medicine, College of Medicine, Taipei Medical University, Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes – sequence: 10 givenname: Ya-Wen orcidid: 0000-0002-6080-8859 surname: Chen fullname: Chen, Ya-Wen email: ywc@nhri.edu.tw organization: National Institute of Cancer Research, National Health Research Institutes, Ph.D. Program for Aging, Graduate Institute of Basic Medical Science, China Medical University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40069143$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ks1u1DAUhSNUREvpC7BAltiwCfg_yQqhAcpIlVhQ1tb1T4KrxJ7ayUjzAH1vPDOltCzIxpF97nevj8_L6iTE4KrqNcHvCWbth8wJa7saU1FjLHhX02fVGSWiqTtM-cmj_9PqIucbXD4hiRTiRXXKMZYd4eysurteppiQceNYW5f81lm0_nFJBNqkOMXZZdR7naIeIc8oOZMWP08uzMgHFBOMKN8uMMUlHxjIQDI-xAnQ1gNafSYECnfjgt3XDOPOxHE3e1NQpcGQYJp8GF5Vz3sYs7u4X8-rn1-_XK--1VffL9erT1e14R2fay27HvdE4hYa2jZMkL7VmlPZA4DQRAKVpuManLRNzx00hlGt26ahHe2pZufV-si1EW7UJvkJ0k5F8OqwEdOgIJXpRqfAWeJ62WvTCN4KC1YDZpJhw6y1jBfWxyNrs-jJWVPuV-x4An16EvwvNcStIqTtGspEIby7J6R4u7g8q8nnvYsQXDFUMdLI0ghLVqRv_5HexCWF4tVBRYhoKSmqN49Hepjlz3MXAT0KTIo5J9c_SAhW-1ipY6xUiZU6xErRUsSORbmIw-DS397_qfoN_XvR7A |
Cites_doi | 10.4161/cc.8.23.10238 10.1038/s41388-019-0731-8 10.1038/s41587-020-0546-8 10.7150/thno.47901 10.1038/ncomms10305 10.3390/cancers12010061 10.1128/MCB.22.14.5157-5172.2002 10.1158/0008-5472.CAN-12-4150 10.3390/cancers13061230 10.1016/j.cell.2017.10.044 10.1186/s13046-022-02300-w 10.1016/j.canlet.2020.03.004 10.1016/j.ccr.2009.12.041 10.1093/carcin/bgt035 10.1002/ijc.32613 10.1016/j.cytogfr.2012.07.003 10.18632/oncotarget.18175 10.1016/j.canlet.2014.07.028 10.1002/ijc.32193 10.1371/journal.pone.0043593 10.3389/froh.2021.686337 10.1038/ng.3225 10.1016/j.ccell.2023.02.015 10.1016/j.molcel.2017.10.003 10.1111/j.1365-2559.2007.02873.x 10.1158/0008-5472.CAN-12-1949 10.1186/s13046-022-02456-5 10.1186/s12935-020-01255-2 10.1128/MCB.20.4.1436-1447.2000 10.2147/OTT.S294725 10.1186/bcr2615 10.1007/s00418-008-0530-8 10.3390/biology12071002 10.1016/j.oraloncology.2007.08.012 10.3390/cancers12071718 10.1038/s41573-018-0004-1 10.1016/j.bbrc.2012.09.115 10.1177/1533033820971670 10.1038/nrc1877 10.3389/fonc.2019.00356 10.1002/path.4173 10.1186/s40659-017-0108-9 10.1172/JCI144888 10.1186/s40164-024-00531-5 10.18632/oncotarget.3372 10.1038/nrc.2016.73 10.1158/1078-0432.CCR-17-1776 10.3389/fimmu.2020.594775 10.1016/j.ccell.2023.02.016 10.1152/physrev.00048.2019 10.1016/j.cytogfr.2006.10.001 10.1089/jir.2016.0103 10.1158/0008-5472.CAN-14-1354 10.1016/j.ajpath.2021.02.010 10.18632/oncotarget.5995 10.1038/s41388-022-02540-2 10.1016/S0021-9258(18)68561-8 |
ContentType | Journal Article |
Copyright | The Author(s) 2025 2025. The Author(s). Copyright Nature Publishing Group Dec 2025 The Author(s) 2025 2025 |
Copyright_xml | – notice: The Author(s) 2025 – notice: 2025. The Author(s). – notice: Copyright Nature Publishing Group Dec 2025 – notice: The Author(s) 2025 2025 |
DBID | C6C AAYXX CITATION NPM 3V. 7X7 7XB 88A 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M2P M7P PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI Q9U 7X8 5PM DOA |
DOI | 10.1038/s41389-025-00549-2 |
DatabaseName | Springer Nature OA Free Journals CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2157-9024 |
EndPage | 13 |
ExternalDocumentID | oai_doaj_org_article_aed1ef6fbc75485dadba03630c3ddd34 PMC11897235 40069143 10_1038_s41389_025_00549_2 |
Genre | Journal Article |
GrantInformation_xml | – fundername: Ministry of Health and Welfare (Ministry of Health and Welfare, Taiwan) grantid: MOHW 113-TDU-B-222-134012 funderid: https://doi.org/10.13039/100008903 – fundername: National Health Research Institutes (NHRI) grantid: NHRI CA-113-PP-04 funderid: https://doi.org/10.13039/501100004737 – fundername: National Science and Technology Council, NSTC 112-2314-B-400-005 – fundername: Ministry of Health and Welfare (Ministry of Health and Welfare, Taiwan) grantid: MOHW 113-TDU-B-222-134012 – fundername: National Health Research Institutes (NHRI) grantid: NHRI CA-113-PP-04 |
GroupedDBID | 0R~ 53G 5VS 7X7 88I 8FE 8FH 8FI 8FJ AAJSJ ABDBF ABUWG ACGFS ACUHS ADBBV AENEX AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBLON EBS FYUFA GNUQQ GROUPED_DOAJ HCIFZ HMCUK HYE KQ8 LK8 M2P M7P M~E NAO OK1 PGMZT PHGZT PIMPY PQQKQ PROAC RNT RNTTT RPM UKHRP AASML AAYXX CITATION PHGZM SNYQT NPM 3V. 7XB 88A 8FK K9. PKEHL PQEST PQGLB PQUKI Q9U 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c494t-b69f0f1608a7287351f8bb426faaa5b16a26c94bae6d7f4ea7c32bb877292f2b3 |
IEDL.DBID | DOA |
ISSN | 2157-9024 |
IngestDate | Wed Aug 27 01:06:09 EDT 2025 Thu Aug 21 18:34:32 EDT 2025 Fri Jul 11 04:48:32 EDT 2025 Fri Jul 18 05:21:03 EDT 2025 Sat Mar 15 01:20:51 EDT 2025 Tue Jul 01 05:17:03 EDT 2025 Wed Mar 12 01:32:00 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | 2025. The Author(s). Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c494t-b69f0f1608a7287351f8bb426faaa5b16a26c94bae6d7f4ea7c32bb877292f2b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-8706-2439 0000-0002-6080-8859 |
OpenAccessLink | https://doaj.org/article/aed1ef6fbc75485dadba03630c3ddd34 |
PMID | 40069143 |
PQID | 3176115821 |
PQPubID | 2041913 |
PageCount | 13 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_aed1ef6fbc75485dadba03630c3ddd34 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11897235 proquest_miscellaneous_3176343063 proquest_journals_3176115821 pubmed_primary_40069143 crossref_primary_10_1038_s41389_025_00549_2 springer_journals_10_1038_s41389_025_00549_2 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2025-03-11 |
PublicationDateYYYYMMDD | 2025-03-11 |
PublicationDate_xml | – month: 03 year: 2025 text: 2025-03-11 day: 11 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: United States – name: New York |
PublicationTitle | Oncogenesis (New York, NY) |
PublicationTitleAbbrev | Oncogenesis |
PublicationTitleAlternate | Oncogenesis |
PublicationYear | 2025 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | VJ Tuominen (549_CR58) 2010; 12 X Wu (549_CR28) 2017; 50 R Kalluri (549_CR32) 2006; 6 M Nurmik (549_CR29) 2020; 146 R Kalluri (549_CR4) 2016; 16 PJ Lee (549_CR56) 2022; 41 Y Hassona (549_CR14) 2013; 34 C Zhang (549_CR37) 2020; 20 JG Rheinwald (549_CR55) 2002; 22 AM Richardson (549_CR44) 2018; 24 ZS Lin (549_CR57) 2012; 7 PF Dos Santos (549_CR22) 2017; 37 S Pavlides (549_CR17) 2009; 8 MJ Goldman (549_CR26) 2020; 38 CD Swaim (549_CR25) 2017; 68 KE de Visser (549_CR1) 2023; 41 N Fujii (549_CR7) 2012; 41 LF Gao (549_CR43) 2022; 41 AJ Daly (549_CR9) 2008; 44 A De Vincenzo (549_CR12) 2019; 145 549_CR30 X Zhang (549_CR51) 2020; 10 B Sainz Jr (549_CR24) 2014; 74 J Burks (549_CR21) 2015; 6 549_CR35 IA Sevostyanova (549_CR39) 2012; 427 N Erez (549_CR13) 2010; 17 X Wu (549_CR42) 2020; 478 S Wen (549_CR40) 2021; 14 A Avgustinova (549_CR11) 2016; 7 A Sgorbissa (549_CR18) 2012; 23 RH Chen (549_CR23) 2020; 11 DE Costea (549_CR8) 2013; 73 CH Lee (549_CR31) 2013; 230 J Li (549_CR34) 2024; 13 MA Dickson (549_CR54) 2000; 20 SV Puram (549_CR36) 2017; 171 X Chen (549_CR3) 2019; 18 YC Yen (549_CR53) 2015; 6 A Calon (549_CR27) 2015; 47 549_CR48 549_CR49 JB Andersen (549_CR19) 2006; 17 G Biffi (549_CR10) 2021; 101 X Yang (549_CR41) 2019; 9 W Zeng (549_CR50) 2023; 42 MG Kellermann (549_CR5) 2007; 51 G Caligiuri (549_CR45) 2023; 41 549_CR52 KJ Bienkowska (549_CR6) 2021; 2 G Lorusso (549_CR2) 2008; 130 Y Fu (549_CR46) 2017; 8 YL Chen (549_CR20) 2019; 38 T Fiaschi (549_CR16) 2012; 72 Y Zou (549_CR47) 2021; 191 S Tang (549_CR15) 2014; 353 T Luo (549_CR38) 2020; 19 E Van Obberghen-Schilling (549_CR33) 1988; 263 |
References_xml | – volume: 8 start-page: 3984 year: 2009 ident: 549_CR17 publication-title: Cell Cycle doi: 10.4161/cc.8.23.10238 – volume: 38 start-page: 4480 year: 2019 ident: 549_CR20 publication-title: Oncogene doi: 10.1038/s41388-019-0731-8 – volume: 38 start-page: 675 year: 2020 ident: 549_CR26 publication-title: Nat Biotechnol doi: 10.1038/s41587-020-0546-8 – volume: 10 start-page: 12044 year: 2020 ident: 549_CR51 publication-title: Theranostics doi: 10.7150/thno.47901 – volume: 7 year: 2016 ident: 549_CR11 publication-title: Nat Commun doi: 10.1038/ncomms10305 – ident: 549_CR52 doi: 10.3390/cancers12010061 – volume: 22 start-page: 5157 year: 2002 ident: 549_CR55 publication-title: Mol Cell Biol doi: 10.1128/MCB.22.14.5157-5172.2002 – volume: 73 start-page: 3888 year: 2013 ident: 549_CR8 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-12-4150 – ident: 549_CR35 doi: 10.3390/cancers13061230 – volume: 171 start-page: 1611 year: 2017 ident: 549_CR36 publication-title: Cell doi: 10.1016/j.cell.2017.10.044 – volume: 41 start-page: 81 year: 2022 ident: 549_CR43 publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-022-02300-w – volume: 478 start-page: 93 year: 2020 ident: 549_CR42 publication-title: Cancer Lett doi: 10.1016/j.canlet.2020.03.004 – volume: 17 start-page: 135 year: 2010 ident: 549_CR13 publication-title: Cancer Cell doi: 10.1016/j.ccr.2009.12.041 – volume: 34 start-page: 1286 year: 2013 ident: 549_CR14 publication-title: Carcinogenesis doi: 10.1093/carcin/bgt035 – volume: 145 start-page: 2827 year: 2019 ident: 549_CR12 publication-title: Int J Cancer doi: 10.1002/ijc.32613 – volume: 23 start-page: 307 year: 2012 ident: 549_CR18 publication-title: Cytokine Growth Factor Rev doi: 10.1016/j.cytogfr.2012.07.003 – volume: 8 start-page: 57813 year: 2017 ident: 549_CR46 publication-title: Oncotarget doi: 10.18632/oncotarget.18175 – volume: 353 start-page: 133 year: 2014 ident: 549_CR15 publication-title: Cancer Lett doi: 10.1016/j.canlet.2014.07.028 – volume: 146 start-page: 895 year: 2020 ident: 549_CR29 publication-title: Int J cancer doi: 10.1002/ijc.32193 – volume: 7 start-page: e43593 year: 2012 ident: 549_CR57 publication-title: PLoS One doi: 10.1371/journal.pone.0043593 – volume: 2 year: 2021 ident: 549_CR6 publication-title: Front Oral Health doi: 10.3389/froh.2021.686337 – volume: 47 start-page: 320 year: 2015 ident: 549_CR27 publication-title: Nat Genet doi: 10.1038/ng.3225 – volume: 41 start-page: 434 year: 2023 ident: 549_CR45 publication-title: Cancer cell doi: 10.1016/j.ccell.2023.02.015 – volume: 68 start-page: 581 year: 2017 ident: 549_CR25 publication-title: Mol cell doi: 10.1016/j.molcel.2017.10.003 – volume: 51 start-page: 849 year: 2007 ident: 549_CR5 publication-title: Histopathology doi: 10.1111/j.1365-2559.2007.02873.x – volume: 72 start-page: 5130 year: 2012 ident: 549_CR16 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-12-1949 – volume: 41 start-page: 254 year: 2022 ident: 549_CR56 publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-022-02456-5 – volume: 20 year: 2020 ident: 549_CR37 publication-title: Cancer Cell Int doi: 10.1186/s12935-020-01255-2 – volume: 20 start-page: 1436 year: 2000 ident: 549_CR54 publication-title: Mol Cell Biol doi: 10.1128/MCB.20.4.1436-1447.2000 – volume: 14 start-page: 1205 year: 2021 ident: 549_CR40 publication-title: OncoTargets Ther doi: 10.2147/OTT.S294725 – volume: 12 start-page: R56 year: 2010 ident: 549_CR58 publication-title: Breast Cancer Res doi: 10.1186/bcr2615 – volume: 130 start-page: 1091 year: 2008 ident: 549_CR2 publication-title: Histochem Cell Bio doi: 10.1007/s00418-008-0530-8 – ident: 549_CR49 doi: 10.3390/biology12071002 – volume: 44 start-page: 646 year: 2008 ident: 549_CR9 publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2007.08.012 – ident: 549_CR30 doi: 10.3390/cancers12071718 – volume: 18 start-page: 99 year: 2019 ident: 549_CR3 publication-title: Nat Rev Drug Discov doi: 10.1038/s41573-018-0004-1 – volume: 41 start-page: 444 year: 2012 ident: 549_CR7 publication-title: J Oral Pathol Med Off Publ Int Assoc Oral Pathologists Am Acad Oral Pathol – volume: 427 start-page: 649 year: 2012 ident: 549_CR39 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2012.09.115 – volume: 19 start-page: 153303382097167 year: 2020 ident: 549_CR38 publication-title: Technol Cancer Res Treat doi: 10.1177/1533033820971670 – volume: 6 start-page: 392 year: 2006 ident: 549_CR32 publication-title: Nat Rev Cancer doi: 10.1038/nrc1877 – volume: 9 start-page: 356 year: 2019 ident: 549_CR41 publication-title: Front Oncol doi: 10.3389/fonc.2019.00356 – volume: 230 start-page: 298 year: 2013 ident: 549_CR31 publication-title: J Pathol doi: 10.1002/path.4173 – volume: 50 year: 2017 ident: 549_CR28 publication-title: Biol Res doi: 10.1186/s40659-017-0108-9 – ident: 549_CR48 doi: 10.1172/JCI144888 – volume: 13 start-page: 63 year: 2024 ident: 549_CR34 publication-title: Exp Hematol Oncol doi: 10.1186/s40164-024-00531-5 – volume: 6 start-page: 7221 year: 2015 ident: 549_CR21 publication-title: Oncotarget doi: 10.18632/oncotarget.3372 – volume: 16 start-page: 582 year: 2016 ident: 549_CR4 publication-title: Nat Rev Cancer doi: 10.1038/nrc.2016.73 – volume: 24 start-page: 420 year: 2018 ident: 549_CR44 publication-title: Clin Cancer Res Off J Am Assoc Cancer Res doi: 10.1158/1078-0432.CCR-17-1776 – volume: 11 year: 2020 ident: 549_CR23 publication-title: Front Immunol doi: 10.3389/fimmu.2020.594775 – volume: 41 start-page: 374 year: 2023 ident: 549_CR1 publication-title: Cancer Cell doi: 10.1016/j.ccell.2023.02.016 – volume: 101 start-page: 147 year: 2021 ident: 549_CR10 publication-title: Physiol Rev doi: 10.1152/physrev.00048.2019 – volume: 17 start-page: 411 year: 2006 ident: 549_CR19 publication-title: Cytokine Growth Factor Rev doi: 10.1016/j.cytogfr.2006.10.001 – volume: 37 start-page: 246 year: 2017 ident: 549_CR22 publication-title: J Interferon Cytokine Res doi: 10.1089/jir.2016.0103 – volume: 74 start-page: 7309 year: 2014 ident: 549_CR24 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-14-1354 – volume: 191 start-page: 857 year: 2021 ident: 549_CR47 publication-title: Am J Pathol doi: 10.1016/j.ajpath.2021.02.010 – volume: 6 start-page: 41837 year: 2015 ident: 549_CR53 publication-title: Oncotarget doi: 10.18632/oncotarget.5995 – volume: 42 start-page: 224 year: 2023 ident: 549_CR50 publication-title: Oncogene doi: 10.1038/s41388-022-02540-2 – volume: 263 start-page: 7741 year: 1988 ident: 549_CR33 publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)68561-8 |
SSID | ssj0000561655 |
Score | 2.3473291 |
Snippet | Cancer-associated fibroblast (CAF) recruitment and activation within the tumor microenvironment (TME) are increasingly acknowledged as drivers of oral squamous... Abstract Cancer-associated fibroblast (CAF) recruitment and activation within the tumor microenvironment (TME) are increasingly acknowledged as drivers of oral... |
SourceID | doaj pubmedcentral proquest pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 6 |
SubjectTerms | 13/1 13/105 13/21 13/51 38/39 38/90 42/109 631/443/319 631/67/1536 631/67/2327 631/67/327 631/80/84 64/60 Actin Apoptosis Cancer CD11a antigen Cell Biology Fibroblast activation protein Fibroblasts Gene expression Glucose metabolism Glycolysis Human Genetics Immunohistochemistry Internal Medicine Lactic acid Leukocyte migration LFA-1 antigen Lymphocytes Medicine Medicine & Public Health Metastases Oncology Oral cancer Oral carcinoma Oral squamous cell carcinoma Smooth muscle Squamous cell carcinoma Tumor microenvironment Tumors Vimentin |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ZbxMxELagSIgXxM3SgozEG1jd9bHHE4JCKUjlhVbKm-WzjUR20-ymUn9A_zczziZVuF6zVjKZ-Wx_c-wMIW9cVeWOB8ewVQyTtg7MgqPFbKWUdcJ4l8Z0Hn8vj07lt4majAG3fiyrXJ-J6aD2ncMY-T7ccyWwl5oX7-cXDKdGYXZ1HKFxm9zB1mWI6mpSbWIsyI5LpcZ3ZXJR7_cSE3MMZ7giWWkY37qPUtv-v3HNP0smf8ubpuvo8AG5P_JI-mFl-IfkVmgfkbvHY6b8Mbk-Wc66BcW4PPOAssvg6dcfXwpF56kAL_Q0gqfcWWDPA4Vjb7GcpoJzOm0pvrVP-4ulwbhA-g7qcOZQ280MvZwaevCpKAxbD9Ad6NnPKwDUFchCsUtmKvmagdxPyOnh55ODIzaOXGBONnJgtmxiHosyr00FvpRQRaythVs8GmOULUrDS9dIa0LpqyiDqZzg1tbI0XnkVjwlO23XhueEeh58LCP4Qw0s5Llx0dfe5BGwmxuvMvJ2rXg9X3XW0CkjLmq9MpMGM-lkJs0z8hFts1mJXbHTB93iTI-bTJvgiwC_aV0FjpjyxluDiercCe-9kBnZW1tWj1u11zfAysjrzWPYZKhd0wZQdFojJHhXIiPPVkDYSCKx2TOwzozUWxDZEnX7STs9T428wbnDoW-gindrNN3I9W9dvPj_39gl93gCuGBFsUd2hsUyvATmNNhXaXv8ApAcGsA priority: 102 providerName: ProQuest – databaseName: Springer Nature HAS Fully OA dbid: AAJSJ link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELaqVkJcEG9CCzISN7CIX4lzXAqlrFQubaXeLD_LSmxSdrOV-gP6vxl7k0UL5cA18W5GM5_tbzzjGYTeurouHQuOpFIxRFgViAVHi9haSuu48S636Tz5Vh2fi-mFvNhBbLwLk5P2c0nLvEyP2WEfliJF1EhqvppYRkNg2d1LpdoB23uTyfR0ujlZSZy4knK4IVNydcePt3ahXKz_Lob5d6LkH9HSvAkdPUQPBvaIJ2t5H6Gd0D5G906G-PgTdHu2mncLnE7jiQdsXQePv55-oRJf5bS7sMQR_OPOAmfuMSx2i9Usp5njWYvTXX28_Lky6TQg_wd2qdNQ280Nvp4ZfPiJUkPGtrk9vvxxAzC6AVlwqo2ZE73mIPdTdH70-ezwmAyNFogTjeiJrZpYRlqVytTgQXFJo7IW9u5ojJGWVoZVrhHWhMrXUQRTO86sVYmZs8gsf4Z2264NLxD2LPhYRfCCGhjISuOiV96UERBbGi8L9G5UvL5a19PQOQ7OlV6bSYOZdDaTZgX6mGyzGZlqYecH3eJSD9jQJnga4JvW1eB-SW-8NSk8XTruveeiQAejZfUwQZcaaFMFZFgxWqA3m9cwtZJ2TRtA0XkMF-BT8QI9XwNhI4lIJZ6BaxZIbUFkS9TtN-3sey7fDS5davUGqng_oum3XP_Wxcv_G76P7rMMeE4oPUC7_WIVXgF_6u3rYcL8AtpRGfE priority: 102 providerName: Springer Nature |
Title | Tumor cell-derived ISG15 promotes fibroblast recruitment in oral squamous cell carcinoma via CD11a-dependent glycolytic reprogramming |
URI | https://link.springer.com/article/10.1038/s41389-025-00549-2 https://www.ncbi.nlm.nih.gov/pubmed/40069143 https://www.proquest.com/docview/3176115821 https://www.proquest.com/docview/3176343063 https://pubmed.ncbi.nlm.nih.gov/PMC11897235 https://doaj.org/article/aed1ef6fbc75485dadba03630c3ddd34 |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bb9MwFLZgSIgXxJ3AqIzEG1iL7dhJHruyMSptQmyT-mb5OirRdLTppP0A_jfHTlpWLuKFp0qJVR2d8zn-Ts7JdxB6Y8syt8xbEqViSGEqTwwkWsSUQhjLtbNpTOfxiTw6L8YTMbkx6iv2hHXywJ3j9rR31AcZjC2BXAunndGx-Jhb7pzjSQkUzrwbyVSn6i2pFKL_Sibn1d6yiCU5Eqe3RppSE7Z1EiXB_j-xzN-bJX-pmKaD6PABut8zSDzsLH-IbvnmEbp73NfIH6PvZ6vZfIHjG3niAF9X3uGPpx-owJep9c4vcYAceW6AN7cYHniL1TS1muNpg-P3-nj5baXjG4H0H9jGaUPNfKbx1VTj0XtKNVmPzm3xxddrgNI12IKjPmZq9pqB3U_Q-eHB2eiI9MMWiC3qoiVG1iEPVOaVLiGL4oKGyhg4v4PWWhgqNZO2Loz20pWh8Lq0nBlTRXbOAjP8Kdpp5o1_jrBj3kHEIBOqYSHLtQ2ucjoPgNpcO5Ght2vHq8tOU0OlWjivVBcmBWFSKUyKZWg_xmazMuphpwuAEtWjRP0LJRnaXUdW9Zt0qYA6SSDEFaMZer25Ddsrelc3Hhyd1vAC8iqeoWcdEDaWFFHmGfhmhqotiGyZun2nmX5JEt6Q1sVxb-CKd2s0_bTr77548T988RLdY2kbcELpLtppFyv_CphVawbodjkpB-jOcDg-HcPv_sHJp89wdSRHg7TBfgAXIioS |
linkProvider | Directory of Open Access Journals |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VIgEXxBtDgUWCE6xq7_qVA0LQUhLa9EIq5bbss0QidppHUX4Af4ffyMzGThVet17tlT2ex843O-MZQl6YoogNd4ZhqxiW6tIxDYEW00WWaSOUNWFMZ_84756kn4bZcIv8bP-FwbLKdk8MG7WtDZ6R74KfywG9lDx5OzljODUKs6vtCI2VWhy65XcI2WZvevsg35ecH3wY7HVZM1WAmbSTzpnOOz72SR6XqoBwQWSJL7UGR-WVUplOcsVz00m1crktfOpUYQTXukQYyj3XAp57hVwFxxtjsFcMi_WZDqLxPMuaf3NiUe7OUkwEMpwZi-Cow_iG_wtjAv6Gbf8s0fwtTxvc38EtcrPBrfTdStFuky1X3SHX-k1m_i75MViM6ynFPACzoNXnztLe549JRieh4M_NqIfIvNaA1ucUttnpYhQK3OmootglgM7OFgrPIcIzqMEZR1U9VvR8pOjefpIo1g7sndPTb0tQ4CXQQrErZygxGwPd98jJpQjjPtmu6so9JNRyZ33uIf7qwEIeK-NtaVXswVZiZbOIvGoZLyerTh4yZOBFKVdikiAmGcQkeUTeo2zWK7ELd7hQT09lY9RSOZs4eKc2BQR-mVVWK0yMx0ZYa0UakZ1WsrLZGmbyQpEj8nx9G4wauasqB4wOa0QK0ZyIyIOVIqwpSbG5NKDciJQbKrJB6uadavQ1NA6HYBKHzAErXrfadEHXv3nx6P-f8Yxc7w76R_Kod3z4mNzgQdkFS5Idsj2fLtwTQG1z_TSYCiVfLts2fwH3-1gp |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ZbxMxELZKKlW8IG4WChgJnsDKrr1XHhCiTUNDaVRBK_Vt67NEIrtpjqL8AP4Uv44ZZzdVuN76umt5Z-ew5_OMZwh5qbMs1NxqhqViWKxyyxQALaayJFFaSKN9m87DQbp_En88TU43yM_mLgymVTZrol-oTaXxjLwN-1wK3kvOo7ar0yKOur134wuGHaQw0tq001iqyIFdfAf4Nn3b74KsX3He2zve3Wd1hwGm4048YyrtuNBFaZjLDKCDSCKXKwWblpNSJipKJU91J1bSpiZzsZWZFlypHF1S7rgSMO8NspkhKmqRzZ29wdHn1QkP-uZpktQ3dUKRt6cxhgUZdpBFV6nD-Npu6JsG_M3T_TNh87eord8Me7fJrdqLpe-XaneHbNjyLtk6rOP098iP4_momlCMCjADOn5pDe1_-RAldOzT_-yUOsDplQLffUZh0Z3Mhz7dnQ5LijUD6PRiLvFUws9BNXY8KquRpJdDSXe7USRZ0753Rs-_LUCdF0ALxRqdPuFsBHTfJyfXIo4HpFVWpX1EqOHWuNQBGuvAQB5K7UxuZOjAckJpkoC8bhhfjJd1PQofjxd5sRRTAWIqvJgKHpAdlM1qJNbk9g-qyXlRm3ghrYksfFPpDGBgYqRREsPkoRbGGBEHZLuRbFEvFNPiSq0D8mL1GkwcuStLC4z2Y0QM2E4E5OFSEVaUxFhqGnzegORrKrJG6vqbcvjVlxEHaIkt54AVbxptuqLr37x4_P_feE62wC6LT_3BwRNyk3tdFyyKtklrNpnbp-DCzdSz2lYoObtu8_wFqhFdxA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tumor+cell-derived+ISG15+promotes+fibroblast+recruitment+in+oral+squamous+cell+carcinoma+via+CD11a-dependent+glycolytic+reprogramming&rft.jtitle=Oncogenesis+%28New+York%2C+NY%29&rft.au=Wang%2C+Ssu-Han&rft.au=Chen%2C+Yu-Lin&rft.au=Huang%2C+Shih-Han&rft.au=Fu%2C+Yu-Ke&rft.date=2025-03-11&rft.issn=2157-9024&rft.eissn=2157-9024&rft.volume=14&rft.issue=1&rft.spage=6&rft_id=info:doi/10.1038%2Fs41389-025-00549-2&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2157-9024&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2157-9024&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2157-9024&client=summon |